A soluble factor from trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Mott, G Adam ^a,b   Costales, Jaime A ^a,c   Burleigh, Barbara A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ETS; TRANSFORMING GROWTH FACTOR BETA; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CNN GENE; CONTROLLED STUDY; CTGF GENE; DOWN REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; UNINDEXED SEQUENCE; WOUND HEALING; CELL LINE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GENETICS; HOST PARASITE INTERACTION; METABOLISM; PARASITOLOGY; PHYSIOLOGY; SKIN; SOLUBILITY;

MAMMALIA; PROTOZOA; TRYPANOSOMA CRUZI;

BINDING SITES; CELL LINE; CONNECTIVE TISSUE GROWTH FACTOR; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HOST-PARASITE INTERACTIONS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-ETS; SIGNAL TRANSDUCTION; SKIN; SOLUBILITY; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI; WOUND HEALING;

EID: 80052517596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023482     Document Type: Article

References (66)

1. Giddings OK, Eickhoff CS, Smith TJ, Bryant LA, Hoft DF, (2006) Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun 74: 5549-5560.
2. Yoshida N, (2008) Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol Int 57: 105-109.
3. Epting CL, Coates BM, Engman DM, (2010) Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Exp Parasitol 126: 283-291.
4. Mott GA, Burleigh BA, (2008) The role of host cell lysosomes in Trypanosoma cruzi invasion. Subcell Biochem 47: 165-173.
5. de Avalos SV, Blader IJ, Fisher M, Boothroyd JC, Burleigh BA, (2002) Immediate/Early Response to Trypanosoma cruzi Infection Involves Minimal Modulation of Host Cell Transcription. Journal of Biological Chemistry 277: 639-644.
6. Chen CC, Lau LF, (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41: 771-783.
7. Unnikrishnan M, Burleigh BA, (2004) Inhibition of host connective tissue growth factor expression: a novel Trypanosoma cruzi-mediated response. FASEB Journal 18: 1625-1635.
8. Grotendorst GR, (1997) Connective Tissue Growth Factor: A Mediator of TGF-beta Action on Fibroblasts. Cytokine & Growth Factor Reviews 8: 171-179.
9. Shi-Wen X, Leask A, Abraham D, (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine & Growth Factor Reviews 19: 133-144.
10. Denton CP, Abraham DJ, (2001) Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 13: 505-511.
11. Hofmeister V, Schrama D, Becker JC, (2008) Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother 57: 1-17.
12. Alapati D, Rong M, Chen S, Hehre D, Rodriguez MM, et al. (2011) CTGF Antibody Therapy Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats. Am J Respir Cell Mol Biol.
13. Adler SG, Schwartz S, Williams ME, Arauz-Pacheco C, Bolton WK, et al. (2010) Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol 5: 1420-1428.
14. Chaqour B, Goppelt-Struebe M, (2006) Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins. Febs J 273: 3639-3649.
15. Leask A, Holmes A, Black CM, Abraham DJ, (2003) Connective Tissue Growth Factor Gene Regulation. Journal of Biological Chemistry 278: 13008-13015.
16. Muehlich S, Cicha I, Garlichs CD, Krueger B, Posern G, et al. (2007) Actin-dependent regulation of connective tissue growth factor (CTGF). Am J Physiol Cell Physiol.
17. Muehlich S, Schneider N, Hinkmann F, Garlichs CD, Goppelt-Struebe M, (2004) Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. Atherosclerosis 175: 261-268.
18. Black SA Jr, Palamakumbura AH, Stan M, Trackman PC, (2007) Tissue-specific Mechanisms for CCN2/CTGF Persistence in Fibrotic Gingiva. J Biol Chem 282: 15416-15429.
19. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, et al. (2002) CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC. 62: 1149-1159.
20. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, et al. (2003) C-Jun-NH2-Terminal Kinase Mediates Expression of Connective Tissue Growth Factor Induced by Transforming Growth Factor-{beta}1 in Human Lung Fibroblasts. Am J Respir Cell Mol Biol 28: 754-761.
21. Van Beek J, Kennedy L, Rockel J, Bernier S, Leask A, (2006) The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Research & Therapy 8: R36.
22. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M, (2006) Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program. J Biol Chem 281: 25259-25269.
23. Buchwalter G, Gross C, Wasylyk B, (2004) Ets ternary complex transcription factors. Gene 324: 1-14.
24. Oikawa T, Yamada T, (2003) Molecular biology of the Ets family of transcription factors. Gene 303: 11-34.
25. Liu B, Yu J, Taylor L, Zhou X, Polgar P, (2006) Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. Journal of Cellular Biochemistry 97: 1104-1120.
26. Shi-wen X, Howat SL, Renzoni EA, Holmes A, Pearson JD, et al. (2004) Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK. J Biol Chem 279: 23098-23103.
27. Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, et al. (2003) Constitutive Connective Tissue Growth Factor Expression in Scleroderma Fibroblasts Is Dependent on Sp1. J Biol Chem 278: 41728-41733.
28. Engel ME, McDonnell MA, Law BK, Moses HL, (1999) Interdependent SMAD and JNK Signaling in Transforming Growth Factor-beta-mediated Transcription. J Biol Chem 274: 37413-37420.
29. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, et al. (2001) Peroxisome Proliferator-activated Receptor gamma Inhibits Transforming Growth Factor beta-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3. J Biol Chem 276: 45888-45894.
30. Zhang Y, Feng X-H, Derynck R, (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-[beta]-induced transcription. 394: 909-913.
31. Heasley LE, Han S-Y, (2006) JNK Regulation of Oncogenesis. Molecules and Cells 21: 167-173.
32. Black AR, Black JD, Azizkhan-Clifford J, (2001) Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. Journal of Cellular Physiology 188: 143-160.
33. Wagner EF, (2002) Functions of AP1 (Fos/Jun) in bone development. Annals of the Rheumatic Diseases 61: 40ii-42.
34. Gordan JD, Thompson CB, Simon MC, (2007) HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation. Cancer Cell 12: 108-113.
35. Fahmy RG, Dass CR, Sun L-Q, Chesterman CN, Khachigian LM, (2003) Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nature Medicine 9: 1026-1032.
36. Johnson GL, Nakamura K, (2007) The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1773: 1341-1348.
37. Yi J-H, Park S-W, Kapadia R, Vemuganti R, (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochemistry International 50: 1014-1027.
38. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, et al. (2004) KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation. J Exp Med 199: 1305-1315.
39. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury. Am J Pathol 166: 675-684.
40. Vuolteenaho K, Moilanen T, Moilanen E, (2008) Non-Steroidal Anti-Inflammatory Drugs, Cyclooxygenase-2 and the Bone Healing Process. Basic & Clinical Pharmacology & Toxicology 102: 10-14.
41. Stenson WF, (1997) Cyclooxygenase 2 and wound healing in the stomach. Gastroenterology 112: 645-648.
42. Nian M, Lee P, Khaper N, Liu P, (2004) Inflammatory Cytokines and Postmyocardial Infarction Remodeling. Circulation Research 94: 1543-1553.
43. Marshall AK, Barrett OP, Cullingford TE, Shanmugasundram A, Sugden PH, et al. (2010) ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes. PLoS One 5: e10027.
44. McCarthy SA, Chen D, Yang BS, Garcia Ramirez JJ, Cherwinski H, et al. (1997) Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol 17: 2401-2412.
45. Park JM, Adam RM, Peters CA, Guthrie PD, Sun Z, et al. (1999) AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells. Am J Physiol 277: C294-301.
46. Zhang X, Zhang J, Yang X, Han X, (2007) Several transcription factors regulate COX-2 gene expression in pancreatic beta-cells. Mol Biol Rep 34: 199-206.
47. Yeo SJ, Yoon JG, Yi AK, (2003) Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol Chem 278: 40590-40600.
48. Pendurthi UR, Ngyuen M, Andrade-Gordon P, Petersen LC, Rao LV, (2002) Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol 22: 1421-1426.
49. Han JS, Macarak E, Rosenbloom J, Chung KC, Chaqour B, (2003) Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. Eur J Biochem 270: 3408-3421.
50. Tien Hsu MT, Watson DennisK, (2004) Ets proteins in biological control and cancer. Journal of Cellular Biochemistry 91: 896-903.
51. Trojanowska M, (2000) Ets factors and regulation of the extracellular matrix. Oncogene 19: 6464-6471.
52. Calvet CM, Oliveira FO Jr, Araujo-Jorge TC, Pereira MC, (2009) Regulation of extracellular matrix expression and distribution in Trypanosoma cruzi-infected cardiomyocytes. Int J Med Microbiol 299: 301-312.
53. Alcorn JF, Guala AS, van der Velden J, McElhinney B, Irvin CG, et al. (2008) Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci 121: 1036-1045.
54. Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, et al. (2004) Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 45: 100-109.
55. Dong C, Davis RJ, Flavell RA, (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72.
56. Padilla AM, Simpson LJ, Tarleton RL, (2009) Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol 183: 1245-1252.
57. Van Overtvelt L, Vanderheyde N, Verhasselt V, Ismaili J, De Vos L, et al. (1999) Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect Immun 67: 4033-4040.
58. Majumder S, Kierszenbaum F, (1995) Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human lymphocytes. Infect Immun 63: 4546-4549.
59. Kierszenbaum F, Sztein MB, Beltz LA, (1989) Decreased human IL-2 receptor expression due to a protozoan pathogen. Immunol Today 10: 129-131.
60. Kierszenbaum F, Sztein MB, (1990) Mechanisms underlying immunosuppression induced by Trypanosoma cruzi. Parasitol Today 6: 261-264.
61. Van Overtvelt L, Andrieu M, Verhasselt V, Connan F, Choppin J, et al. (2002) Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol 14: 1135-1144.
62. Gomes NA, Previato JO, Zingales B, Mendonca-Previato L, DosReis GA, (1996) Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the ceramide domain. J Immunol 156: 628-635.
63. Hansen DS, Villacres-Eriksson M, Akerblom L, Hellman U, Segura E, et al. (1998) An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-beta-mediated mechanism. Scand J Immunol 47: 509-516.
64. Goncalves MF, Umezawa ES, Katzin AM, de Souza W, Alves MJM, et al. (1991) Trypanosoma cruzi: Shedding of surface antigens as membrane vesicles. Experimental Parasitology 72: 43-53.
65. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV, (2007) Pathogenesis of Chronic Chagas Heart Disease. Circulation 115: 1109-1123.
66. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, et al. (2006) Rosetta error model for gene expression analysis. Bioinformatics 22: 1111-1121.